ARYA Sciences Acquisition... (ARYE)
10.36
-0.02 (-0.19%)
At close: Jul 13, 2023, 7:52 PM
Company Description
ARYA Sciences Acquisition Corp V does not have significant operations.
It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses in the healthcare and healthcare-related industries.
The company was incorporated in 2021 and is based in New York, New York.
ARYA Sciences Acquisition Corp V

Country | United States |
IPO Date | Jul 13, 2021 |
Industry | Shell Companies |
Sector | Financial Services |
Employees | n/a |
CEO | Adam Leo Stone |
Contact Details
Address: 51 Astor Place New York, New York United States | |
Website | n/a |
Stock Details
Ticker Symbol | ARYE |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001852432 |
CUSIP Number | G31658100 |
ISIN Number | KYG316581001 |
Employer ID | 00-0000000 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Adam Leo Stone | Chief Executive Officer & Director |
Michael Seth Altman CFA | Chief Financial Officer & Director |
Konstantin Poukalov | Chief Bus. Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Aug 10, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Jul 28, 2023 | 15-12G | Filing |
Jul 14, 2023 | 25-NSE | Filing |
Jul 10, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
Jul 03, 2023 | 8-K | Current Report |
Jun 13, 2023 | PRE 14A | Filing |
May 15, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
May 12, 2023 | 10-Q | Quarterly Report |
Apr 12, 2023 | 10-K | Annual Report |